In the News

Dr. Gary Gilliland, MD, PhD, has been appointed to TwinStrand Biosciences’ Board of Directors as the company’s fifth board member. Dr. Gilliland brings over 30 years of clinical and research leadership experience, most recently serving as president and director of the Seattle-based Fred Hutchinson Cancer Research Center from 2015 to February 2020. “I am incredibly impressed with the work Dr. Salk and his team are doing to advance the field of DNA sequencing with their innovative Duplex Sequencing technology, which empowers clinicians and researchers to make decisions with previously unthinkable levels of accuracy,” said Dr. Gilliland. “I look forward to working with the TwinStrand team to fully realize the technology’s many applications in the clinic and beyond.”